Turconi, A <br/><br/>
Open-label, multicenter study on the safety, tolerability, and efficacy of Simulect in pediatric renal transplant recipients receiving triple therapy with cyclosporin, mycophenolate, and corticosteroids.  [electronic resource] 

 -  Transplantation proceedings  Mar 2005 
 - 672-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2005.02.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Basiliximab<br/>Biopsy<br/>Cadaver<br/>Child<br/>Cyclosporine--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Graft Rejection--pathology<br/>Histocompatibility Testing<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--immunology<br/>Living Donors<br/>Male<br/>Mycophenolic Acid--therapeutic use<br/>Prospective Studies<br/>Recombinant Fusion Proteins--therapeutic use<br/>Safety<br/>Tissue Donors